These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 17541772

  • 1. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD, Bijelic L, Sugarbaker PH.
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [Abstract] [Full Text] [Related]

  • 2. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L, Yan TD, Sugarbaker PH.
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [Abstract] [Full Text] [Related]

  • 3. Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination.
    Mohamed F, Chang D, Sugarbaker PH.
    J Surg Oncol; 2003 May; 83(1):5-12; discussion 12-3. PubMed ID: 12722090
    [Abstract] [Full Text] [Related]

  • 4. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
    Bijelic L, Yan TD, Sugarbaker PH.
    J Surg Oncol; 2008 Sep 15; 98(4):295-9. PubMed ID: 18726900
    [Abstract] [Full Text] [Related]

  • 5. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A.
    Ann Surg Oncol; 2012 Jan 15; 19(1):110-4. PubMed ID: 21701929
    [Abstract] [Full Text] [Related]

  • 6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
    Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL.
    Br J Surg; 2006 Oct 15; 93(10):1270-6. PubMed ID: 16838392
    [Abstract] [Full Text] [Related]

  • 7. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD, Chu F, Links M, Kam PC, Glenn D, Morris DL.
    Eur J Surg Oncol; 2006 Dec 15; 32(10):1119-24. PubMed ID: 16887321
    [Abstract] [Full Text] [Related]

  • 8. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
    Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, Chang D.
    Ann Surg Oncol; 2006 May 15; 13(5):635-44. PubMed ID: 16523363
    [Abstract] [Full Text] [Related]

  • 9. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
    Schomas DA, Miller RC, Donohue JH, Gill S, Thurmes PJ, Haddock MG, Quevedo JF, Gunderson LL.
    Ann Surg; 2009 Apr 15; 249(4):588-95. PubMed ID: 19300231
    [Abstract] [Full Text] [Related]

  • 10. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.
    Ann Surg Oncol; 2008 Feb 15; 15(2):526-34. PubMed ID: 18043976
    [Abstract] [Full Text] [Related]

  • 11. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients.
    Esquivel J, Sugarbaker PH.
    Ann Surg; 2001 Aug 15; 234(2):198-205. PubMed ID: 11505065
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis.
    Marcotte E, Sideris L, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Dubé P.
    Ann Surg Oncol; 2008 Oct 15; 15(10):2701-8. PubMed ID: 18654822
    [Abstract] [Full Text] [Related]

  • 16. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Yan H, Pestieau SR, Shmookler BM, Sugarbaker PH.
    Mod Pathol; 2001 Mar 15; 14(3):164-71. PubMed ID: 11266521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.
    Ann Surg Oncol; 2009 Feb 15; 16(2):463-72. PubMed ID: 19082859
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.